Q4 2010 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net income—
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived-$1,869,000—
Free Cash Flowderived-$1,910,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
no prior Q4 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR